Research News - July 2, 2021

         
 
July 2, 2021
ANNOUNCEMENTS
 

1. Audio Visual Upgrades Coming to Simches, CNY 149, and CNY 114
2. Share Your Bulfinch Building Memory!
3. Invitation to Submit Abstracts for MGH Clinical Research Day 2021
4. Register for the Mass General Brigham Employee Alert System
5. Conversion from Opti-Freight to SCS Logistics (Mayo Clinic)
6. New TEDxMGH Talk! Embracing Your Weirdness

EVENTS
 

1. QI Bootcamp for Clinical Researchers and Study Staff
2. ClinicalTrials.gov Registration and Results Reporting
3. Learn Something New! Series
4. Studying Resistance in Cancer: A Special seminar on collaboration with Gaddy Getz and Dejan Juric
5. Design and Conduct of Clinical Trials
6. MGH will celebrate the 19th Annual Clinical Research Day
7. 2021 Virtual Tumor Course

FUNDING OPPORTUNITIES
 

1. COVID Funding Opportunities
2. Interim Support Funding 21-3
3. The Smith Family Awards for Excellence in Biomedical Research
4. Collaborative Program Grant for Multidisciplinary Teams (RM1 – Clinical Trial Optional)
5. Harrington Prize for Innovation in Medicine
6. Jeanette Ives Erickson Research Institute Grant – Deadline Extended!
7. NIH Research Supplements to Promote Diversity in Health-Related Research
8. The Chong Jin Park Innovative Early Career Pilot Award in Aging and Palliative Care & The Ki Sub Joung Innovative Early Career Faculty Pilot Award in Aging and Palliative Care 2021
9. Job Research Foundation Announces 4th Round of Funding
10. NIH Research Project Grant (R01) Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities
11. T32 Postdoctoral Program to Enrich Translation and Multimodal Research in Alzheimer’s Disease and Related Dementia (PET/MR in ADRD) - T32 AG066592
12. Limited Submission Funding Opportunities
13. Foundation Funding Opportunities

In Case You Missed It
 
Reminders of recently posted funding opportunities, deadlines and events
 
ANNOUNCEMENTS
 
1. Audio Visual Upgrades Coming to Simches, CNY 149, and CNY 114

We have recently received approval to update the audio-visual systems in the following rooms:

  • Simches Building Room 3.110
  • Simches Building Room 3.120
  • CNY Building 114 Rooms D1 & D2 (combinable rooms)
  • CNY Building 149 Room 7.213 (Isselbacher)

The upgrades include a complete overhaul of the systems – new cameras, microphones, and Zoom capabilities. System design will begin in July and work will commence in September.

 
2. Share Your Bulfinch Building Memory!

MGH staff are invited to share their “MGH Memory” about the Bulfinch building.

Do you have a memorable moment that you’d like to share with the MGH community? Is Bulfinch home to your favorite historic photo or is there an element of architecture that you love? Do you remember how you felt when you first walked through the historic Ether Dome? Did you have a meaningful conversation, meeting or experience in a Bulfinch hallway or conference room? Did you proudly pose for a photograph on the Bulfinch stairs to celebrate a success? Did a family member work here and you walked through the building as a child – and now walk the same route as an employee?

Share your memories or photographs with us in advance of the 200th anniversary of the admission of MGH’s first patient! Email them to Apollo@partners.org.  

 
3. Invitation to Submit Abstracts for MGH Clinical Research Day 2021

MGH Investigators are invited to submit abstracts for MGH Clinical Research Day 2021. Abstract Submission deadline is July 15, 2021. Mandatory criteria for abstracts include; manuscripts published or submitted for publication between September 2020 and July 2021 and submissions must be about clinical research or educational research conducted at MGH.

All abstracts that present novel data from a clinical research study will be considered for the hospital-wide awards in the following categories: Clinical & Outcomes Research, Translational Research, Team and Health Professions Education Research. MGH Departments will also be giving monetary awards.

Please, submit abstracts here by July 15, 2021.

If you have any questions, please contact Tiereny Morrison-Rohlfs.

 
4. Register for the Mass General Brigham Employee Alert System

The Mass General Brigham Employee Alert System (EAS) is a critical part of our emergency preparedness and response efforts, ensuring all personnel can be immediately alerted about potentially life-threatening situations and other time-sensitive emergency incidents that could arise in our facilities.

One of the best ways that employees can receive EAS alerts is to be registered in the system to receive cell phone text messaging. Immediately receiving critical alerts on your phone when an emergency happens is an important way that you can stay safe at work, regardless of your location.

We are asking for your help by registering your cell phone in the Mass General Brigham EAS if you have not done so already. It is important to note the EAS is not used for routine alerts, patient care issues or regular hospital communications. EAS alerts are used very sparingly but, if needed, could be required off hours where cell phone access, rather than email, is critical. The cell phone numbers registered in the EAS are never shared publicly or used for any other hospital purposes.

One of the fastest ways to register your phone (or confirm your cell phone registration) in the EAS is through the Mass General Brigham My Profile function:

  1. Access My Profile.
  2. Login with your Mass General Brigham username and password.
  3. Under “My Profile Information” – select “Update my Employee Alert System.”
  4. Select the box confirming you agree to receive notifications, and enter your cell phone number.
  5. Hit save and your information will be updated in the Employee Alert System.

For more detailed instructions, troubleshooting and/or to learn about downloading the EAS Everbridge app onto your smartphone as an alternative to EAS text messaging, view the EAS page on The Pulse.

The Mass General Brigham emergency preparedness and security programs will always work to provide the safest possible work and care environment for our staff, patients and visitors. Registering your cell phone with the EAS is one important way that you can help take full advantage of the services we support for your safety.

 
5. Conversion from Opti-Freight to SCS Logistics (Mayo Clinic)

We are pleased to announce that MGB has contracted with Mayo Clinic Supply Chain Solutions for a new shipping program. This new program goes into effect July 6, 2021. The program will enable Mass General Brigham to more effectively manage and reduce shipping costs by allowing you—the shipper—to make cost-effective choices regarding your shipping needs.

Implementing this new program means that we will no longer support OptiFreight® as our shipping partner, and access to the OptiFreight portal will be discontinued. Furthermore, MGB has chosen to move to one consolidated setup for FedEx, including a centralized FedEx.com setup to protect MGB assets, resources, and processes. MGB will no longer be creating new FedEx account numbers where an existing account may be used as part of the process change. 

Note: The current implementation does not impact UPS process. The UPS process will remain as it is today with no changes.

Account Validation (What do I need to do as a FedEx user?):
Please send an email to scslogistics@mayo.edu on or before June 30, 2021 with the following information to keep your account active. Failure to respond will result in deactivation of your account:

  • The email address that you currently use
  • The physical business address from which you send shipments, including:
  • Street address
  • City
  • ZIP code
  • Phone number

FedEx.com Training:

  • Will be available through HealthStream
  • Below are the dates for webinar-based training hosted by Mayo Clinic Supply Chain Solutions. To accommodate the busy schedules of our employees, Mayo is offering classes on different dates and times. Please check the schedule below and register for a class that supports your schedule. We request that you all attend and take advantage of this training. Training sessions are typically 45 minutes in duration and provide information on creating labels, utilizing best practices, and employing tips and tricks to effectively manage shipping costs.
  • You’ll also receive an email from scslogistics@mayo.edu with a new user ID and password that you’ll use to create outbound shipping labels directly in www.FedEx.com instead of the OptiFreight portal. 

Concurrently, we are updating our FedEx inbound account number with all suppliers within the Peoplesoft system.     

Classes for Fedex.com Training for OptiFreight Users
Hosted by Supply Chain Solutions developed by Mayo Clinic

This class is presented via Zoom and is specifically designed for users
currently using OptiFreight’s Portal.

Users will need to obtain a new user ID and password.  To register for a new user ID, please email scslogistics@mayo.edu with your date of attendance from the list below, your full name, contact phone number, and physical shipping address.

  • Wednesday, July 7, 2021, 3:30 – 4:30 PM (EDT)
  • Friday, July 9, 2021, 10:00 – 11:00 AM (EDT)

Please contact Shawn Carmody, Contract Manager-IT, Supply chain contracts at email: SCARMODY@PARTNERS.ORG for additional questions regarding  transition to the new Freight program.

 
6. New TEDxMGH Talk! Embracing Your Weirdness

Dr. Rajani C. LaRocca, a physician and author, embraces her penchant for writing and the importance of perseverance—of learning, growing, and discovering and appreciating all the links between one’s career and one’s passion. View video here. The TEDxMGH videos present inspirational stories from the MGH community, including how people have handled challenges through innovation, resilience, vulnerability, and connection. These monthly 10-12 min. stories by your colleagues cover far-reaching topics – from antiracism and social justice to climate change, laughter, coping with loss, COVID-19, and living and working with depression. View previous videos on the TEDxMGH Apollo page. If you are interested in contributing to this series, please click here to apply.

 
Back to top
EVENTS
 
1. QI Bootcamp for Clinical Researchers and Study Staff

Wednesday, July 7, 10:00 AM – 12:30 PM, Zoom

Speaker: Pamela Richtmyer, Director, MGB Human Research Quality Improvement Program
The QI Program Clinical Research Bootcamp is a “clinical research 101” for study staff and investigators. The course is not only an introduction to clinical research for new investigators and study staff but also good review for experienced study teams.  Many teams include this course as part of the onboarding process for new study staff.  The course covers research regulations, GCP guidelines, and institutional policies relevant to the day to day conduct of clinical research.  Topics include:

  • Informed Consent documentation
  • Study Documentation (subject files, source documents, and data collection forms)
  • Unanticipated Problems, Deviations and Violations
  • Investigational Product Management and Accountability
  • Regulatory Binder and Essential Documents
  • ClinicalTrials.Gov
  • Inspections and audits 
  • Other relevant topics

*This course is worth 2 RCR Credits.

Register here.

Please contact  Tiereny Morrison-Rohlfs with any questions.

Click here to learn more about QI Bootcamp for Clinical Researchers and Study Staff

 
2. ClinicalTrials.gov Registration and Results Reporting

Friday, July 9, 9:00 – 10:30 AM, Zoom

Speaker: Pamela Richtmyer, Director, MGB Human Research Quality Improvement Program
This course will provide participants with information on the requirements for clinical trials registration on ClinicalTrials.gov, results reporting, record maintenance, and consequences for noncompliance.  The course is recommended for investigators and study staff involved in the conduct of clinical trials registration and results reporting or those interested in registering research studies to meet ICMJE publication requirements.   *This course is worth 1 RCR credit.

Register here.

Please contact Tiereny Morrison-Rohlfs with questions.

Click here to learn more about ClinicalTrials.gov Registration and Results Reporting

 
3. Learn Something New! Series

Friday, July 9 – September 2021, 11:00 AM – 12:00 PM Zoom

Click here for a full list of topics 

Clinical research is complicated. It is governed by regulations, guidelines, and institutional policies. It involves people inside and outside of the institution, in clinical areas, doing financial management, etc. But you don’t have to do it all on your own! Join the DCR’s network of study coordinators, research assistants, and project managers to learn something new about different clinical research operations topics. With something for everyone, these sessions cover how to’s on protocols, basic study designs, informed consent, managing your day to day, and many more.  

To get the most out of this program, you should have already completed the CITI Training in Human Subjects Research and Clinical Research Conduct: Research Staff Training prior to enrolling. It is also recommended that you take Good Clinical Practice in an Academic Research Institution prior to enrolling. 

Please browse a full list of topics here and register for each individually.

Please contact tmorrison-rohlfs@partners.org with questions.

Click here to learn more about the Learn Something New! Series

 
4. Studying Resistance in Cancer: A Special seminar on collaboration with Gaddy Getz and Dejan Juric
Thursday, July 15, 2021, 1:00 – 2:30 PM, Zoom

Hosted by the MGH-Broad Working Group
Drs. Getz and Juric are experts at finding and nurturing productive collaborations across disciplines. We will hear research highlights from their work, strategies
to find great partners, and how they keep the collaborations running smoothly.

The Termeer Center brings together cutting-edge research resources and provides a foundation for collaborations among physicians and investigators from a
broad spectrum of biomedical disciplines, to speed the discovery and delivery of new targeted therapies to patients with early and advanced stage cancers. The
Getz lab collaborates with an extraordinary and wide-ranging group of investigators from across MGH and other institutions.

Drs. Getz and Juric gave the Broad-MGH Working Group an exciting preview of this presentation and we are thrilled to bring this inspiring topic to the whole
MGH research community!

Please click here to join the Zoom Meeting

 
5. Design and Conduct of Clinical Trials        

Tuesdays and Thursdays: September 02 – November 09, 2021, 5:00 – 6:30pm

Sponsored by the MGH Division of Clinical Research, the Division of Infectious Diseases, and the Department of Psychiatry

Applications due August 23, 2021

Design and Conduct of Clinical Trials is an intensive thirteen-session course offered from early-September through late October. Physicians with a serious interest in clinical trials will be introduced to theoretical and practical issues facing clinical researchers.  Course participants will learn how to envision, plan, develop and execute effective clinical trials. Study content includes research designs, protocols, ethical patient recruitment, informed consent, regulations, and clinical trial management.

The course is ideally suited for clinical fellows starting their research years, junior faculty pursuing careers in clinical research, and physicians with an interest in becoming more actively involved in clinical research. 

All participants are expected to use the course curriculum to develop and present a trial design at the final session of the course. 

Enrollment is limited to facilitate interaction and individual attention. To ensure placement in the course, early application is recommended. All applications will be reviewed after the August 23rd deadline.
To submit an application and/or view a course schedule, please go to: Design and Conduct of Clinical Trials. *This site is not compatible with Internet Explorer, please use Chrome or Edge
Please contact Teresa La with any questions.

 
6. MGH will celebrate the 19th Annual Clinical Research Day

Thursday, October 14, 2021, 8:00 AM – 12:00 PM

To learn more about MGH Clinical Research Day 2021 please visit the portal.

 
7. 2021 Virtual Tumor Course

Monday, November 2, 2021 – Thursday, November 4, 2021

36TH Critical Issues in Tumor Microenvironment Angiogenesis, Metastasis and Immunology

For comprehensive information about this course, including faculty, schedule, and pricing,
please visit the 36th Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology website

The “36th Annual Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology” course, directed by Professor Rakesh K. Jain, will continue to offer the best in critical analysis of what is currently known about the tumor microenvironment, angiogenesis, metastasis, immunology, metabolism and chronobiology. This will include chimeric antigen receptor (CAR) T-cell therapies and the role of microbiome as newly introduced topics this year. The faculty is internationally recognized. They will present their latest findings from their clinics and laboratories. The goal is to highlight key gaps in present knowledge of cancer and outline future directions for research at the bench, in the clinic, and in drug development.

The course will continue its four-day online webinar-based live lecture format. Learning formats will include didactic lectures, Q&A and group discussions. The faculty will encourage an open discussion and will provide critical comments on challenges and future opportunities in research in cancer and in establishment of novel therapy approaches and biomarkers to guide treatment. The aim of this course is to analyze and synthesize the most up-to-date findings. Our faculty will present valuable information in a systematic and comprehensive framework, along with a critical review of various measurement techniques. This course is dedicated to helping to improve clinical translation of this knowledge and competence, leading to improved cancer treatment.  

Harvard Medical School’s secure online registration.

Click here to for an overview 

Click here to view the brochure

 
Back to top
FUNDING OPPORTUNITIES
 
1. COVID Funding Opportunities

Please visit the new MGB web page for COVID funding opportunities that provides a central database for researchers to view open and competitive funding announcements.

We have aggregated opportunities from federal and private funding sources including NIH, DoD, CDC, EPA, foundations, and more.  The database defaults to sorting by award amount and can also be sorted by deadline or filtered by research focus.

Upcoming deadlines:

Recently added:

 
2. Interim Support Funding 21-3

The Executive Committee on Research (ECOR) is now accepting applications for Interim Support Funding. 

What are they?
Interim Support Funding
The Interim Support Funding (ISF) Program is open to Principal Investigators during a lapse or delay in their research funding from the NIH or another Federal agency (e.g., the National Science Foundation, the Department of Defense).  Investigators must have applied for independent, long-term support (R01, R21, U01 and P01). The intent of the program is to rescue strong scientific programs that are in need of bridge funding in order to sustain their research. Applications will be accepted regardless of percentile or score, including applications that were not discussed. Financial need and the impact of the COVID pandemic will be taken into account.

When is the deadline?
Monday, August 2, 2021 - 5:00 PM

How do I learn more and apply?
Interim Support Funding - Click here

 
3. The Smith Family Awards for Excellence in Biomedical Research

The Smith Family Awards for Excellence in Biomedical Research
“The mission of the Awards Program is to launch the careers of newly independent biomedical researchers with the ultimate goal of achieving medical breakthroughs. The three‚Äźyear Award supports newly independent faculty engaged in basic biomedical research. Investigators in the physical sciences (physics, chemistry and engineering) whose projects focus on biomedical science are also encouraged to apply. While basic research projects involving human subjects, data, and samples are eligible, clinical trials research is beyond the scope of this program.

“In recognition of the importance of research collaboration by the scientific community, collaboration is an additional, but not required, positive ancillary factor. These projects may involve researchers within and/or outside MGH.”

This opportunity is open to full-time faculty at MGH whose Assistant Professor appointment began (or will begin) between 10/1/18 and 4/1/22. The award is $300,000 over three years, inclusive of 5% institutional overhead. 

The foundation now has a two-stage application process, and there are no limits on the number of applications from an institution. An internal selection process is no longer required. All eligible faculty at MGH should apply directly to the sponsor.

Please contact Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to this opportunity. They will be able to advise you on the application process.

Initial proposal deadline: Tuesday, August 10, 2021 at 12:00 Noon (Those applicants who make it to the second stage will be invited to submit a full proposal in November).

Click here to learn more and apply.

 
4. Collaborative Program Grant for Multidisciplinary Teams (RM1 – Clinical Trial Optional)

Letters of intent are now being accepted by the Executive Committee on Research (ECOR) for the NIH Collaborative Program Grant for Multidisciplinary Teams

What are they?
“This funding opportunity announcement (FOA) is designed to support highly integrated research teams of three to six PDs/PIs to address ambitious and challenging research questions that are important for the mission of NIGMS and are beyond the scope of one or two investigators. Collaborative program teams are expected to accomplish goals that require considerable synergy and managed team interactions. Project goals should not be achievable with a collection of individual efforts or projects. Teams are encouraged to consider far-reaching objectives that will produce major advances in their fields.

Applications that are mainly focused on the creation, expansion, and/or maintenance of community resources, creation of new technologies, or infrastructure development are not appropriate for this FOA.”

MGH is eligible to submit one application to the NIH.

How much is the award?
Most awards will be between $700,000-$900,000 direct costs

When is the deadline?  

MGH letter of intent deadline: July 28, 2021 at 5:00pm
LOI deadline: December 27, 2021
Full application to NIH: January 27, 2022

What are the internal guidelines?
Please submit a 2-3 page letter of intent, along with a NIH biosketch, to ecor@mgh.harvard.edu

Be sure to include the following information:

  1. Applicant's name, job title, and the applicant's contact information
  2. State the project title and hypothesis, outline the research aim(s) and methods
  3. A brief discussion of the project's potential impact

In the event that there is more than one applicant, the internal LOI will be used to assess if a review and selection process will be needed. ECOR will notify all interested applicants by September 2021.

How do I learn more about the opportunity?
NIH RFA PAR-20-103 – Click here

 
5. Harrington Prize for Innovation in Medicine

The Harrington Prize for Innovation in Medicine, presented by the American Society for Clinical Investigation and the Harrington Discovery Institute at University Hospitals – part of The Harrington Project for Discovery & Development – honors a physician-scientist who has moved science forward with notable achievements in innovation, creativity and potential for clinical application.
This annual prize includes:

  • An unrestricted $20,000 honorarium
  • The Harrington Prize Lecture, delivered at the 2022 AAP/ASCI/APSA Joint Meeting
  • Participation at the 2022 Harrington Discovery Institute Symposium
  • A personal essay, published in the Journal of Clinical Investigation

This prize requires an institutional nomination. MGH is not limited in the number of nominees we can submit. If you are interested, please contact MGH ECOR at ecor@partners.org by July 9, 2021 to be considered.

 
6. Jeanette Ives Erickson Research Institute Grant – Deadline Extended!

The Jeanette Ives Erickson Research Institute Grant Promoting Excellence in Patient Care is presented annually to a mid-career, PhD-prepared nurse researcher with dedication and passion for inquiry that improves patient and family outcomes. The researcher is expected to have a clearly defined area of research concentration (funded and unfunded) that has been disseminated and translated into patient care and is eligible for a new direction or application.  The proposed science complements an area(s) of research interest identified by the Yvonne L. Munn Center for Nursing Research, available at: http://www.mghpcs.org/MunnCenter/ and leads to externally funded grant submissions. 

Selection Criteria:

  • PhD in nursing.
  • Postdoctoral research fellowship preparation preferred.
  • Internal and external funding records to advance nursing research.
  • Emerging research has a clear focus on using a variety of methodological approaches to uncover new knowledge.
  • Dissemination of research findings nationally and beyond through invited presentations and peer-reviewed publications.
  • Focus on original research with potential for translation of results into practice.
  • Demonstrated leadership and national research recognition.

To set up an appointment to learn more about the Jeanette Ives Erickson Research Institute Grant, please email: Dottie Jones, Ed.D , ANP, FAAN DJONES9@mgh.harvard.edu to answer questions about how to focus your inquiry, select your team, and write the proposal.

HOW TO SUBMIT: Please click HERE for more information and to submit a letter of intent!
For general information about the Jeanette Ives Erickson Research Institute Grant, please visit the Munn Center website: http://www.mghpcs.org/munncenter/Munn_Research_Award.asp

 
7. NIH Research Supplements to Promote Diversity in Health-Related Research

Fostering diversity in the scientific research workforce is a key component of the NIH strategy to identify, develop, support and maintain the quality of our scientific human capital NOT-OD-20-031.

This administrative supplement is designed to provide support for research experiences for individuals from diverse backgrounds throughout the continuum from high school to the faculty level. Continuation of this program in the future will depend on the evaluation of the career outcomes of the supported individuals as well as continuing assessments of the diversity of the scientific workforce.

Please click here to learn more.

 
8. The Chong Jin Park Innovative Early Career Pilot Award in Aging and Palliative Care & The Ki Sub Joung Innovative Early Career Faculty Pilot Award in Aging and Palliative Care 2021

Applications are now being accepted by the Mongan Institute Center for Aging and Serious Illness for the The Chong Jin Park Innovative Early Career Pilot Award in Aging and Palliative Care & The Ki Sub Joung Innovative Early Career Faculty Pilot Award in Aging and Palliative Care

What is it?
The Chong Jin Park Innovative Early Career Pilot Award in Aging and Palliative Care & The Ki Sub Joung Innovative Junior Faculty Pilot Award in Aging and Palliative Care will support innovative applied clinical research or implementation pilot project(s) (T3-4) focused on improving the evidence base for aging or serious illness care. This RFA will fund initial pilot work to provide data and planning for an externally funded, full-scale project grant (e.g. K award, R01, PCORI etc.). Applicants who hold a full-time appointment in any MGH Department, are pursuing a research career, and meet the eligibility criteria below are encouraged to apply.

The Chong Jin Park Innovative Early Career Pilot Award in Aging and Palliative Care will support research focused on achieving health equity and improving the lives of older people and or those with serious illness through research in population and health care delivery science. The Ki Sub Joung Innovative Early Career Faculty Pilot Award in Aging and Palliative Care will support research focused on improving the lives of older people and or those with serious illness, with an emphasis on the care of those living with cognitive impairment or their caregivers.

How much is the award?
The award is $50,000 for one year plus 15% indirect costs and is effective October 1, 2021.  

When is the deadline?
August 16, 2021 by 5 pm EDT

How do I learn more and apply?

 
9. Job Research Foundation Announces 4th Round of Funding

$400,000 in Grants Available to Researchers Investigating Causes/Treatments of Rare Multisystem Immunodeficiency Disorder

The Job Research Foundation, which seeks to help find a cure for Job Syndrome by providing the global scientific community with additional opportunities to further research into the rare multisystem immunodeficiency disorder, has announced the fourth round of grant funding. The Foundation will award two two-year grants in the amount of $200,000 each to scientific researchers who are investigating the causes of, and treatments for, Job Syndrome. Grant applications can be found online at https://www.jobresearchfoundation.org/grant-proposal-application . Deadline to apply is October 15, 2021.

The long-term goal of the Foundation is to help advance research to find a cure for Job Syndrome. In the short term, the Foundation hopes the research will improve the treatments for patients suffering from the rare disorder.

To date the organization has funded a total of ten research projects across the world. In 2019, Job Research Foundation awarded four grants in the first round of funding to researchers from Australia, Spain, Germany, and the United States. In 2020, four grants were awarded to researchers in the United States and the United Kingdom in the second round of funding. This year’s recipients are based in the United States and in Germany.

Special consideration will be given to research focused on Job Syndrome and Pulmonary Function. Previous applicants can apply in subsequent years to extend their research. The application process is open to researchers world-wide and awardees will be announced between December 2021 and January 2022.

The Job Research Foundation seeks to not only help find a cure for Job Syndrome by providing the scientific community with additional opportunities to further research into the rare multisystem immunodeficiency disorder, but also hopes that investigators will research treatments to help those suffering with Job Syndrome. Job Syndrome, also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), was discovered in 1966 and is a multisystem immunodeficiency disorder found in males and females worldwide. Visit https://www.jobresearchfoundation.org/ for additional details.

 
10.  NIH Research Project Grant (R01) Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities

The National Institute of Neurological Disorders and Stroke seeks to promote diversity in all of its research programs and to increase the participation of underrepresented groups. As the US population becomes increasingly diverse, reflection of that diversity among the biomedical research workforce is vital to our science enterprise and the NIH research mission (See NOT-OD-20-031). NIH is committed to implementing approaches to address the funding gap for researchers from diverse backgrounds and “committed to instituting new ways to support diversity, equity, and inclusion, and identifying and dismantling any policies and practices that may harm our workforce and our science”.

This NOSI utilizes the NIH parent R01 announcement to encourage Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) from diverse backgrounds to conduct and contribute to the research areas of the NINDS.

This notice applies to due dates on or after June 5, 2021 and subsequent receipt dates through May 8, 2023. 

Click here to learn more.

 
11. T32 Postdoctoral Program to Enrich Translation and Multimodal Research in Alzheimer’s Disease and Related Dementia (PET/MR in ADRD) - T32 AG066592
The primary mission of this program is to promote the development of a diverse, translational research workforce that is capable of participating and/or leading cross-disciplinary team science relevant for the treatment and prevention of Alzheimer’s disease and AD-related dementias.  The trainee will pursue a targeted research project under the mentorship of world-class researchers in the Harvard research community in three key areas:
  1. biology of aging and neurodegeneration;
  2. data sciences, computational biology, statistics, math/engineering/physics;
  3. drug discovery and development
Most T32 faculty are within the MGH Martinos Center for Biomedical Imaging and/or Massachusetts Alzheimer’s Disease Research Center.  Training includes targeted coursework, didactic lectures, and a dedicated T32 lecture series. General training includes research conduct, diversity and inclusion, mentoring, career development, and grant development activities.

Eligibility: PhD, MD, MD/PhD and U.S. citizen or permanent resident (see NIH PAR-18-524), with rolling admission for 4 training slots.  Our goal is to recruit a truly diverse T32 trainee pool that is highly representative of URM and women trainees.

Additional information: Please see  https://pricelab.martinos.org/t32-adrd/ for further information including application instructionsPlease submit questions to:  Krystal Whitfield (T32 Administrative Contact) at T32ADRD@mgh.harvard.edu

 
12. Limited Submission Funding Opportunities

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process            
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org.  In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

  • Name of the Principal Investigator with appropriate contact information
  • A descriptive title of the potential application
  • Brief description of the project
  • Brief description of why you specifically should be selected to receive institutional nomination for this award

If there is more than one MGH investigator interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities                                                                                                                                        
Please click here for more information and for our internal deadlines.

  • Centers for HIV Structural Biology (U54 Clinical Trial Not Allowed)

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please let us know at ecor@mgh.harvard.edu.

 
13. Foundation Funding Opportunities

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these opportunities.  Note that proposals are still routed through the standard Insight/Research Management process.

Please be aware that any grant that brings in less than 15% in indirect costs (IDC) will need to be supplemented up to the 15% equivalent by existing investigator or departmental sundry funds. Resolution of this issue must occur prior to submitting a proposal.  Training fellowships from foundations, public charity, and non-profit organizations are excluded from this minimum IDC requirement.

Week of 07/02/21

  • Chronic Pain Medicine Research Grant, American Society of Regional Anesthesia and Pain Medicine (ASRA). $200,000. Funder Deadline: September 15
  • Smith Family Awards Program for Excellence in Biomedical Research, The Medical Foundation/Health Resources in Action (HRiA). $300,000. Funder Deadline: August 10
  • General Research Grants, March of Dimes Foundation COVID! $300,000. Funder Deadline: September 10
  • Judith Graham Pool (JGP) Postdoctoral Research Fellowship, National Hemophilia Foundation (NHF). $104,000. Funder Deadline: July 19
  • Dermatology Research Fellowship in Skin of Color, Pfizer Global Medical Grants (GMG) NEW! $80,000. Funder Deadline: July 16
  • Child Development Fund: Diet and/or Microbiome Research Projects, The Waterloo Foundation (TWF). ≈$84,000. Funder Deadline: October 10
  • Resuscitation or Acute Critical Care Seed Grants, ZOLL Foundation NEW! $50,000. Funder Deadline: September 30
Back to top
In Case You Missed It
 
Reminders of recently posted funding opportunities, deadlines and events

MGH Town Hall Meeting Recordings

MGB Community Connects

Mentor MGB

Check out the Coronavirus Resource Guide for MGH Researchers!

NIH Update for Week Ending July 2, 2021

PCORI - Click here for the latest funding opportunities from the Patient-Centered Outcomes Research Institute (PCORI).

Looking for something you saw in a previous Research News release? Check out our archive!

Back to top
 
RESOURCES  

ECOR Website

Mass General Research Institute

MGH Research Intranet

Research Help and How-To

Your email address is currently listed as:%%emailaddr%%.

Click here to edit your profile or to change your email address for receipt of information about MGH Research.

Click here to subscribe to MGH Research Email announcements.
Executive Committee On Research (ECOR) Massachusetts General Hospital
125 Nashua Street, Suite 822, Boston, MA 02114
ecor@mgh.harvard.edu